Abstract
Marfan syndrome is an autosomal dominant disorder affecting mainly the skeletal, ocular and cardiovascular systems. Most cases are caused by mutations in the fibrillin-1 gene (FBN1), although there are some reports on deletions involving FBN1 and other additional genes. We report a male patient who was first evaluated at 4 years of age. Echocardiogram showed a mildly dilated aortic sinus. He also had a history of muscular ventral septal defect which was closed spontaneously and trivial mitral regurgitation. Other phenotypic features include frontal bossing, anteverted ears, joint hyperlaxity, learning disability, skin striae, and height and weight in the >97th centile but no other diagnostic findings of MFS and does not fulfill the revised Ghent criteria. Chromosomal microarray analysis showed a deletion of approximately 36.8 kb at 15q21.1, which starts in intron 6 and ends in intron 9 and includes three FBN1 exons. Sequence analysis of the breakpoint region confirmed the deletion and revealed a concomitant insertion of a retrotransposon within the intron 6/intron 9 region. The intragenic deletion of exons 7–9 was likely the result of a retrotransposition event by a MAST2-SVA element mediated by repetitive sequences.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
De Paepe, A., Devereux, R. B., Dietz, H. C., Hennekam, R. C. & Pyeritz, R. E . Revised diagnostic criteria for the Marfan syndrome. Am. J. Med. Genet. 62, 417–426 (1996).
Mizuguchi, T., Collod-Beroud, G., Akiyama, T., Abifadel, M., Harada, N., Morisaki, T. et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 36, 855–860. (2004).
Loeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275–281. (2005).
Pannu, H., Tran-Fadulu, V. & Milewicz, D. M . Genetic basis of thoracic aortic aneurysms and aortic dissections. Am. J. Med. Genet. C Semin. Med. Genet. 139C, 10–16. (2005).
Putnam, E. A., Cho, M., Zinn, A. B., Towbin, J. A., Byers, P. H. & Milewicz, D. M . Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am. J. Med. Genet. 62, 233–242 (1996).
Faivre, L., Collod-Beroud, G., Loeys, B. L., Child, A., Binquet, C., Gautier, E. et al. Effect of mutation type and location on clinical outcome in 1013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am. J. Hum. Genet. 81, 454–466. (2007).
Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921. (2001).
Callinan, P. A. & Batzer, M. A . Retrotransposable elements and human disease. Genome Dyn. 1, 104–115. (2006).
Kaer, K. & Speek, M . Retroelements in human disease. Gene 518, 231–241. (2013).
Solyom, S. & Kazazian, H. H. Jr. Mobile elements in the human genome: implications for disease. Genome Med. 4, 12. (2012).
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V. et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl Acad. Sci. USA 100, 5280–5285. (2003).
Hancks, D. C., Goodier, J. L., Mandal, P. K., Cheung, L. E. & Kazazian, H. H. Jr. Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum. Mol. Genet. 20, 3386–3400. (2011).
Raiz, J., Damert, A., Chira, S., Held, U., Klawitter, S., Hamdorf, M. et al. The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res. 40, 1666–1683. (2012).
Loeys, B. L., Dietz, H. C., Braverman, A. C., Callewaert, B. L., De Backer, J., Devereux, R. B. et al. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 47, 476–485. (2010).
Ades, L. C., Sullivan, K., Biggin, A., Haan, E. A., Brett, M., Holman, K. J. et al. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am. J. Med. Genet. A 140, 1047–1058. (2006).
Hutchinson, S., Furger, A., Halliday, D., Judge, D. P., Jefferson, A., Dietz, H. C. et al. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype? Hum. Mol. Genet. 12, 2269–2276. (2003).
Faivre, L., Khau Van Kien, P., Callier, P., Ruiz-Pallares, N., Baudoin, C., Plancke, A. et al. De novo 15q21.1q21.2 deletion identified through FBN1 MLPA and refined by 244 K array-CGH in a female teenager with incomplete Marfan syndrome. Eur J. Med. Genet. 53, 208–212. (2010).
Dordoni, C., Ciaccio, C., Santoro, G., Venturini, M., Cavallari, U., Ritelli, M. et al. Marfan syndrome: report of a complex phenotype due to a 15q21.1 contiguos gene deletion encompassing FBN1, and literature review. Am. J. Med. Genet. A 173, 200–206. (2016).
Hilhorst-Hofstee, Y., Hamel, B. C., Verheij, J. B., Rijlaarsdam, M. E., Mancini, G. M., Cobben, J. M. et al. The clinical spectrum of complete FBN1 allele deletions. Eur. J. Hum. Genet. 19, 247–252. (2011).
Colovati, M. E., da Silva, L. R., Takeno, S. S., Mancini, T. I., N Dutra, A. R., Guilherme, R. S. et al. Marfan syndrome with a complex chromosomal rearrangement including deletion of the FBN1 gene. Mol. Cytogenet. 5, 5. (2012).
Quinonez, S. C., Gelehrter, T. D. & Uhlmann, W. R . A Marfan syndrome-like phenotype caused by a neocentromeric supernumerary ring chromosome 15. Am. J. Med. Genet. A 173, 268–273. (2016).
Corson, G. M., Chalberg, S. C., Dietz, H. C., Charbonneau, N. L. & Sakai, L. Y . Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics 17, 476–484. (1993).
Saharinen, J. & Keski-Oja, J . Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol. Biol. Cell 11, 2691–2704. (2000).
Aoyama, T., Tynan, K., Dietz, H. C., Francke, U. & Furthmayr, H . Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. Hum. Mol. Genet. 2, 2135–2140. (1993).
Furtado, L. V., Wooderchak-Donahue, W., Rope, A. F., Yetman, A. T., Lewis, T., Plant, P. et al. Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification. BMC Med. Genet. 12, 119. (2011).
Singh, K. K., Elligsen, D., Liersch, R., Schubert, S., Pabst, B., Arslan-Kirchner, M. et al. Multi-exon out of frame deletion of the FBN1 gene leading to a severe juvenile onset cardiovascular phenotype in Marfan syndrome. J. Mol. Cell Cardiol. 42, 352–356. (2007).
Blyth, M., Foulds, N., Turner, C. & Bunyan, D . Severe Marfan syndrome due to FBN1 exon deletions. Am. J. Med. Genet. A 146A, 1320–1324. (2008).
Liu, W., Schrijver, I., Brenn, T., Furthmayr, H. & Francke, U . Multi-exon deletions of the FBN1 gene in Marfan syndrome. BMC Med. Genet. 2, 11. (2001).
Hancks, D. C. & Kazazian, H. H. Jr. Roles for retrotransposon insertions in human disease. Mob. DNA 7, 9. (2016).
Xiong, H., Wang, S., Kobayashi, K., Jiang, Y., Wang, J., Chang, X. et al. Fukutin gene retrotransposal insertion in a non-Japanese Fukuyama congenital muscular dystrophy (FCMD) patient. Am. J. Med. Genet. A 149A, 2403–2408. (2009).
Takasu, M., Hayashi, R., Maruya, E., Ota, M., Imura, K., Kougo, K. et al. Deletion of entire HLA-A gene accompanied by an insertion of a retrotransposon. Tissue Antigens 70, 144–150. (2007).
Udaka, T., Okamoto, N., Aramaki, M., Torii, C., Kosaki, R., Hosokai, N. et al. An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome. Am. J. Med. Genet. A 143A, 721–726. (2007).
Vogt, J., Bengesser, K., Claes, K. B., Wimmer, K., Mautner, V. F., van Minkelen, R. et al. SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints. Genome Biol. 15, R80. (2014).
Wimmer, K., Callens, T., Wernstedt, A. & Messiaen, L . The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion. PLoS Genet. 7, e1002371. (2011).
Damert, A., Raiz, J., Horn, A. V., Lower, J., Wang, H., Xing, J. et al. 5′-Transducing SVA retrotransposon groups spread efficiently throughout the human genome. Genome Res. 19, 1992–2008. (2009).
Bantysh, O. B. & Buzdin, A. A . Novel family of human transposable elements formed due to fusion of the first exon of gene MAST2 with retrotransposon SVA. Biochemistry (Mosc) 74, 1393–1399. (2009).
Hancks, D. C., Ewing, A. D., Chen, J. E., Tokunaga, K. & Kazazian, H. H. Jr. Exon-trapping mediated by the human retrotransposon SVA. Genome Res. 19, 1983–1991. (2009).
Zabolotneva, A. A., Bantysh, O., Suntsova, M. V., Efimova, N., Malakhova, G. V., Schumann, G. G. et al. Transcriptional regulation of human-specific SVAF(1) retrotransposons by cis-regulatory MAST2 sequences. Gene 505, 128–136. (2012).
Acknowledgements
This work was funded by grants BMRC 06/1/50/19/485 from the Biomedical Research Council, Agency for Science, Technology and Research, Republic of Singapore and NMRC/CG/006/2013 from the National Medical Research Council, Ministry of Health, Republic of Singapore. We thank Dustin Hancks and Haig Kazazian for helpful discussion.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Brett, M., Korovesis, G., Lai, A. et al. Intragenic multi-exon deletion in the FBN1 gene in a child with mildly dilated aortic sinus: a retrotransposal event. J Hum Genet 62, 711–715 (2017). https://doi.org/10.1038/jhg.2017.32
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2017.32
This article is cited by
-
Retrotransposon insertion as a novel mutational cause of spinal muscular atrophy
Human Genetics (2023)
-
LINE-1 ORF1p does not determine substrate preference for human/orangutan SVA and gibbon LAVA
Mobile DNA (2020)
-
High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer
Scientific Reports (2019)
